Phase I dose-escalation study of tenecteplase, a third-generation fibrinolytic agent, combined with neuronavigation-assisted stereotactic minimally invasive puncture, in patients with acute spontaneous deep cerebral haemorrhage
Zhiyou Wu(Dana-Farber Cancer Institute), Yong Cao(Capital Medical University), Ni Yang(Capital Medical University), Yuming Jiao(Capital Medical University), Pengqi Wang(Capital Medical University), Shaozhi Zhao(Beijing Tian Tan Hospital), Mingze Wang(Capital Medical University), Jinyi Tang(Carter Center), Qiheng He(Capital Medical University), Duolao Wang(Liverpool School of Tropical Medicine), Ran Huo(Beijing Tian Tan Hospital)
Cited by 0
Related Papers
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
|Science Immunology|2022|366
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
|Science Translational Medicine|2022|129
Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study
|Journal of neurosurgery|2017|82
Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K/Akt/NF-κB Signaling Pathway
|Nutrients|2015|79
Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score–matched analysis
|Journal of neurosurgery|2017|61